Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with advanced ovarian cancer or pancreatic cancer through laboratory testing, whose cancer has not responded to at least one previous treatment, and whose tumour tissue has tested positive for a specific protein called mesothelin.
- People whose cancer can be measured using a CT or MRI scan, meeting specific size requirements as defined by standard medical guidelines (confirm with trial site).
- People who have a reasonable level of physical functioning (able to carry out some daily activities) and whose major organs such as the heart, liver, and kidneys are working adequately (confirm with trial site).
- People whose doctors estimate they have a life expectancy of more than 3 months.
- Women who could become pregnant must have a negative pregnancy blood test before starting the trial, and must agree to use a highly effective method of contraception for up to 1 year after the last dose of the study treatment.
Who may not be able to join:
- Women who are currently pregnant or breastfeeding.
- People who have any active infection that is not under control, including conditions such as active tuberculosis or active hepatitis B virus (HBV) infection.
- People who have previously received any treatment that specifically targets the mesothelin protein.
- People who have a history of autoimmune disease (conditions where the immune system attacks the body's own tissues).
- People who the trial doctor believes will be unable or unwilling to follow the requirements of the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identification of Maximum Tolerated Dose (MTD)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.